A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trialYuxiang Ma, Hongyun Zhao, Yunpeng Yang et al.|Nature Medicine|2025Cited by 76
<i>Ab initio</i>studies on the stability and electronic structure of<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:mrow><mml:msub><mml:mi>LiCoO</mml:mi><mml:mn>2</mml:mn></mml:msub></mml:mrow></mml:math>(003) surfacesLiyun Hu, Liquan Chen, Zhihua Xiong et al.|Physical Review B|2005Cited by 37
Efficacy and safety of camrelizumab plus apatinib in patients with advanced esophageal squamous cell carcinoma previously treated with immune checkpoint inhibitors (CAP 02 Re-challenge): A single-arm, phase II studyXiangrui Meng, Feng Wang, Ping Lu et al.|European Journal of Cancer|2024Cited by 18